Literature DB >> 18243209

Dietary oxidized linoleic acid lowers triglycerides via APOA5/APOClll dependent mechanisms.

Mahdi Garelnabi1, Krithika Selvarajan, Dmitry Litvinov, Nalini Santanam, Sampath Parthasarathy.   

Abstract

Previously we have shown that intestinal cells efficiently take up oxidized fatty acids (OxFAs) and that atherosclerosis is increased when animals are fed a high cholesterol diet in the presence of oxidized linoleic acid. Interestingly, we found that in the absence of dietary cholesterol, the oxidized fatty acid fed low-density lipoprotein (LDL) receptor negative mice appeared to have lower plasma triglyceride (TG) levels as compared to animals fed oleic acid. In the present study, we fed C57BL6 mice a normal mice diet supplemented with oleic acid or oxidized linoleic acid (at 18 mg/animal/day) for 2 weeks. After the mice were sacrificed, we measured the plasma lipids and collected livers for the isolation of RNA. The results showed that while there were no significant changes in the levels of total cholesterol and high-density lipoprotein cholesterol (HDLc), there was a significant decrease (41.14%) in the levels of plasma TG in the mice that were fed oxidized fatty acids. The decreases in plasma TG levels were accompanied by significant increases (P<0.001) in the expressions of APOA5 and acetyl-CoA oxidase genes as well as a significant (P<0.04) decrease in APOClll gene expression. Oxidized lipids have been suggested to be ligands for peroxisome proliferator-activated receptor (PPAR*). However, there were no increases in the mRNA or protein levels of PPAR* in the oxidized linoleic acid fed animals. These results suggest that oxidized fatty acids may act through an APOA5/APOClll mechanism that contributes to lowering of TG levels other than PPAR* induction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18243209      PMCID: PMC2562931          DOI: 10.1016/j.atherosclerosis.2007.12.026

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  30 in total

1.  Dietary oxidized fatty acids may enhance intestinal apolipoprotein A-I production.

Authors:  Rong Rong; Sumathi Ramachandran; Meera Penumetcha; Nadya Khan; Sampath Parthasarathy
Journal:  J Lipid Res       Date:  2002-04       Impact factor: 5.922

2.  Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.

Authors:  Philippa J Talmud; Emma Hawe; Steve Martin; Michael Olivier; George J Miller; Edward M Rubin; Len A Pennacchio; Steve E Humphries
Journal:  Hum Mol Genet       Date:  2002-11-15       Impact factor: 6.150

3.  Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.

Authors:  Len A Pennacchio; Michael Olivier; Jaroslav A Hubacek; Ronald M Krauss; Edward M Rubin; Jonathan C Cohen
Journal:  Hum Mol Genet       Date:  2002-11-15       Impact factor: 6.150

Review 4.  Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.

Authors:  H W Breuer
Journal:  Curr Med Res Opin       Date:  2001       Impact factor: 2.580

Review 5.  Oxidants and antioxidants in atherogenesis. An appraisal.

Authors:  S Parthasarathy; N Santanam; S Ramachandran; O Meilhac
Journal:  J Lipid Res       Date:  1999-12       Impact factor: 5.922

6.  Apolipoprotein A-V: a novel apolipoprotein associated with an early phase of liver regeneration.

Authors:  H N van der Vliet; M G Sammels; A C Leegwater; J H Levels; P H Reitsma; W Boers; R A Chamuleau
Journal:  J Biol Chem       Date:  2001-09-27       Impact factor: 5.157

7.  Oxidized fatty acids promote atherosclerosis only in the presence of dietary cholesterol in low-density lipoprotein receptor knockout mice.

Authors:  Nadya Khan-Merchant; Meera Penumetcha; Olivier Meilhac; Sampath Parthasarathy
Journal:  J Nutr       Date:  2002-11       Impact factor: 4.798

8.  Lipid peroxides induce expression of catalase in cultured vascular cells.

Authors:  O Meilhac; M Zhou; N Santanam; S Parthasarathy
Journal:  J Lipid Res       Date:  2000-08       Impact factor: 5.922

9.  Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner.

Authors:  P Delerive; C Furman; E Teissier; J Fruchart; P Duriez; B Staels
Journal:  FEBS Lett       Date:  2000-04-07       Impact factor: 4.124

Review 10.  Fibrates after the FIELD study: Some answers, more questions.

Authors:  Anthony S Wierzbicki
Journal:  Diab Vasc Dis Res       Date:  2006-12       Impact factor: 3.291

View more
  7 in total

1.  Dietary Oxidized Linoleic Acids Modulate Fatty Acids in Mice.

Authors:  Chinedu C Ochin; Thomas Wilson; Mahdi Garelnabi
Journal:  J Lipid Atheroscler       Date:  2022-04-29

2.  Platelets oxidative stress in Indian patients with ischemic heart disease.

Authors:  Mahdi Garelnabi; Vinod Gupta; Venkatesan Mallika; Jayashree Bhattacharjee
Journal:  J Clin Lab Anal       Date:  2010       Impact factor: 2.352

Review 3.  The paradox of ApoA5 modulation of triglycerides: evidence from clinical and basic research.

Authors:  Mahdi Garelnabi; Kenton Lor; Jun Jin; Fei Chai; Nalini Santanam
Journal:  Clin Biochem       Date:  2012-09-19       Impact factor: 3.281

Review 4.  Lipid peroxidation and decomposition--conflicting roles in plaque vulnerability and stability.

Authors:  Sampath Parthasarathy; Dmitry Litvinov; Krithika Selvarajan; Mahdi Garelnabi
Journal:  Biochim Biophys Acta       Date:  2008-03-25

5.  13-hydroxy linoleic acid increases expression of the cholesterol transporters ABCA1, ABCG1 and SR-BI and stimulates apoA-I-dependent cholesterol efflux in RAW264.7 macrophages.

Authors:  Ines Kämmerer; Robert Ringseis; Ronald Biemann; Gaiping Wen; Klaus Eder
Journal:  Lipids Health Dis       Date:  2011-11-30       Impact factor: 3.876

6.  Dietary Oxidized Linoleic Acid Modulates Plasma Lipids beyond Triglycerides Metabolism.

Authors:  Mahdi Garelnabi; Gregory Ainsworth; Halleh Mahini; Naseeha Jamil; Chinedu Ochin
Journal:  J Lipids       Date:  2017-11-29

7.  Nutraceuticals as Ligands of PPARγ.

Authors:  Meera Penumetcha; Nalini Santanam
Journal:  PPAR Res       Date:  2012-06-20       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.